Ken Griffin Neuro Sense Therapeutics Ltd. Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 253,997 shares of NRSN stock, worth $276,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
253,997
Previous 34,280 640.95%
Holding current value
$276,856
Previous $43,000 606.98%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.86 - $1.36 $188,956 - $298,815
219,717 Added 640.95%
253,997 $304,000
Q3 2024

Nov 14, 2024
BUY
$0.63 - $1.35 $21,596 - $46,278
34,280 New
34,280 $43,000
Q3 2023

Nov 14, 2023
BUY
$0.71 - $1.47 $8,308 - $17,201
11,702 New
11,702 $8,000

Others Institutions Holding NRSN

# of Institutions
14
Shares Held
647K
Call Options Held
0
Put Options Held
0
View Full List

About NeuroSense Therapeutics Ltd.

NRSN Quotes by TradingView
  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $12.7M
More about NRSN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email